NCT02320513

Brief Summary

This is a pilot study intended to gather data in order to inform future studies about the role of feedback as an incentive for increasing levels of physical activity which could improve health in hemodialysis patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 3, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

October 1, 2015

Status Verified

September 1, 2015

Enrollment Period

8 months

First QC Date

November 3, 2014

Last Update Submit

September 29, 2015

Conditions

Keywords

Exercise

Outcome Measures

Primary Outcomes (1)

  • The effect of physical activity feedback on physical activity levels.

    Physical activity level will be measured by the number of steps each subject takes. The number of steps each subject takes will be recorded and reported to those in one of the two groups. The study will evaluate whether a subject will begin to walk more steps once s/he is informed about the number of steps s/he is taking.

    5 weeks

Study Arms (2)

Control Group

Subjects will wear the activity monitoring device to track their activity between dialysis treatments, however, the feedback from the device will not be shared with them.

Other: Wearing activty monitoring device (Fitbit Flex)Device: Fitbit Flex

Feedback Group

The feedback from the activity monitoring device will be shared with subjects at each visit.

Other: Wearing activty monitoring device (Fitbit Flex)Device: Fitbit Flex

Interventions

Control GroupFeedback Group
Control GroupFeedback Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Receiving hemodialysis three times a week * On hemodialysis for more than 3 months * Between the ages of 18 and 75 years * Able to walk without assistance or assistive devices * Able to read and understand the English language

You may qualify if:

  • Receiving hemodialysis three times a week
  • On hemodialysis for more than 3 months
  • Between the ages of 18 and 75 years
  • Able to walk without assistance or assistive devices
  • Able to read and understand the English language

You may not qualify if:

  • Patient already uses an activity tracker
  • Unstable health: acute infections, congestive heart failure NYHA class 4 and/or unstable angina
  • Hospitalization within the past 3 months for non-access related reasons
  • Known allergies to nickel
  • Unable to physically grip the handheld dynamometer in order to complete the Hand Grip Strength Test
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Avantua Upper East Side Dialysis Center

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Kidney Failure, ChronicMotor Activity

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Peter Kotanko, MD

    Renal Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2014

First Posted

December 19, 2014

Study Start

October 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

October 1, 2015

Record last verified: 2015-09

Locations